Site-specific PEGylation of lidamycin and its antitumor activity

In this study, N-terminal site-specific mono-PEGylation of the recombinant lidamycin apoprotein (rLDP) of lidamycin (LDM) was prepared using a polyethyleneglycol (PEG) derivative (M(w) 20 kDa) through a reactive terminal aldehyde group under weak acidic conditions (pH 5.5). The biochemical propertie...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Liang, Shang, Boyang, Hu, Lei, Shao, Rongguang, Zhen, Yongsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629235/
https://www.ncbi.nlm.nih.gov/pubmed/26579455
http://dx.doi.org/10.1016/j.apsb.2015.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629235/
https://www.ncbi.nlm.nih.gov/pubmed/26579455
http://dx.doi.org/10.1016/j.apsb.2015.03.006

Ejemplares similares